Nebulizers Market size is projected to experience significant growth from 2022 to 2028 owing to the increasing cases of chronic respiratory diseases and soaring geriatric population. Besides, consumption of tobacco, alcohol and sugar-sweetened beverages will further trigger the demand for nebulizers.
Nebulizers are simple medical devices that help to provide the required medication to people with difficulty in breathing adequately. The device is majorly used for the treatment of cystic fibrosis, asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases or disorders. Leading companies are likely to focus on optimized drug delivery performance through portability and shorter nebulization time.
In terms of product, pneumatic nebulizers will contribute a notable share towards the global market during the forecast period. Pneumatic nebulizers have become sought-after for bronchodilator administration to produce a physiological response. Besides, the low cost, effectiveness and convenience attributes of these devices will also foster the demand globally.
Stakeholders expect mesh nebulizers to observe increased traction due to energy efficiency and increased portability. Pharmaceutical companies are using mesh nebulizers for clinical trials involving niche therapy and high-cost areas. Industry players are likely to invest in electronic platforms for the penetration of sophisticated drug delivery features. Besides, recent developments suggest vibrating mesh nebulizers have become popular as a user-friendly and efficient device. So much so that leading companies are gearing to link mesh nebulizers to mobile devices to collate data and enhance patient adherence.
North America nebulizers market will be robust through 2028 led by increased investment in pneumatic and mesh nebulizers. Besides, a soaring number of people suffering from sleep apnea, asthma and tuberculosis will further expedite the penetration of advanced nebulizers. According to the Asthma and Allergy Foundation of America, around 25 million Americans suffer from asthma. Additionally, robust reimbursement policies have made nebulizers trendier across the region.
The competitive scenario indicates leading companies could invest in organic and inorganic strategies, including mergers & acquisitions, innovations, technological advancements and product launches. Koninklijke Philips N.V., Aerogen Limited, Omron Corporation, Vyaire Medical, Inc., Allied Healthcare Products, Inc., Salter Labs, Heyer Medical AG, TaiDoc Technology, PARI Pharma and Vectura Group plc, among others, are some of the major industry leaders boosting global market share.
In July 2020, OMRON rolled out a cost-effective device OMRON NE C106 to boost the ease of use and efficiency of the delivery of the drug.
In January 2021, Aerogen Limited announced the establishment of a new manufacturing operation in Shannon. It could help reduce the risk of supply of quality drug delivery systems as the company continues to invest in nebulizers.
North America and Europe have witnessed profound traction for albuterol inhalers following the onslaught of the COVID-19 pandemic. With an unprecedented rise in respiratory issues, nebulizers are expected to be sought globally. According to the American Lung Association, nebulized therapy is a safe and effective way to take inhaled medications at home during the COVID-19 pandemic. With the trend for integration of cloud computing into nebulizers becoming pronounced, industry participants anticipated to invest in the portfolio. Prominently, home care nebulizers are likely to showcase traction during the forecast period.
Considering the impact of the COVID-19 pandemic, stakeholders are slated to ramp up the production of nebulizers. The integration of IoT and connectivity could be a game-changer in the global market.
Market, by Product
The above information is provided for the following regions and countries: